C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 114 filers reported holding C4 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $38,820 | -36.6% | 20,871 | -6.3% | 0.00% | – |
Q2 2023 | $61,273 | -87.1% | 22,281 | -85.3% | 0.00% | – |
Q1 2023 | $475,888 | -47.1% | 151,557 | -0.6% | 0.00% | – |
Q4 2022 | $899,762 | -32.4% | 152,502 | +0.4% | 0.00% | – |
Q3 2022 | $1,331,000 | +32.2% | 151,836 | +13.7% | 0.00% | – |
Q2 2022 | $1,007,000 | -67.3% | 133,504 | +5.1% | 0.00% | -100.0% |
Q1 2022 | $3,083,000 | -23.7% | 127,072 | +1.3% | 0.00% | 0.0% |
Q4 2021 | $4,040,000 | -19.7% | 125,471 | +11.4% | 0.00% | 0.0% |
Q3 2021 | $5,031,000 | +57.3% | 112,598 | +33.2% | 0.00% | 0.0% |
Q2 2021 | $3,199,000 | +192.9% | 84,545 | +186.4% | 0.00% | – |
Q1 2021 | $1,092,000 | +16.3% | 29,517 | +4.1% | 0.00% | – |
Q4 2020 | $939,000 | – | 28,341 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |